Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:36:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T20:31:10.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error with the standard error page elements, including a Home link and a revision note, indicating the record is temporarily unavailable due to access restrictions.
    Difference
    19%
    Check dated 2026-09-20T20:55:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    There are no reported changes (additions or deletions) to the page content. The study record remains unchanged according to the provided data.
    Difference
    0.1%
    Check dated 2026-09-06T12:15:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a small backend/content update and a new version in the page history.
    Difference
    0.1%
    Check dated 2026-08-30T06:44:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A minor platform patch updates the version from v3.6.4 to v3.6.5, indicating an incremental release that does not appear to change the study details or content.
    Difference
    0.1%
    Check dated 2026-08-08T23:41:14.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.